Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys

RationalePoor cognitive control, including reversal learning deficits, has been reported in children with attention deficit hyperactivity disorder, in stimulant-dependent humans, and in animal models of these disorders; these conditions have each been associated with abnormal catecholaminergic function within the prefrontal cortex.ObjectivesIn the current studies, we sought to explore how elevations in extracellular catecholamine levels, produced by pharmacological inhibition of catecholamine reuptake proteins, affect behavioral flexibility in rats and monkeys.Materials and methodsAdult male Long–Evans rats and vervet monkeys were trained, respectively, on a four-position discrimination task or a three-choice visual discrimination task. Following systemic administration of pharmacological inhibitors of the dopamine and/or norepinephrine membrane transporters, rats and monkeys were exposed to retention or reversal of acquired discriminations.ResultsIn accordance with our a priori hypothesis, we found that drugs that inhibit norepinephrine transporters, such as methylphenidate, atomoxetine, and desipramine, improved reversal performance in rats and monkeys; this was mainly due to a decrease in the number of perseverative errors. Interestingly, the mixed dopamine and norepinephrine transporters inhibitor methylphenidate, if anything, impaired performance during retention in both rats and monkeys, while administration of the selective dopamine transporter inhibitor GBR-12909 increased premature responses but did not alter reversal learning performance.ConclusionsOur results suggest that pharmacological inhibition of the membrane norepinephrine, but not membrane dopamine, transporter is associated with enhanced behavioral flexibility. These data, combined with earlier reports, may indicate that enhanced extracellular catecholamine levels in cortical regions, secondary to norepinephrine reuptake inhibition, improves multiple aspects of inhibitory control over responding in rats and monkeys.

[1]  B. Pitt Psychopharmacology , 1968, Mental Health.

[2]  Gordon D. Logan,et al.  Effects of methylphenidate on inhibitory control in hyperactive children , 1989, Journal of abnormal child psychology.

[3]  T. Robbins,et al.  Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man , 1991, Neuropsychologia.

[4]  P. Goldman-Rakic,et al.  D1 dopamine receptors in prefrontal cortex: involvement in working memory , 1991, Science.

[5]  E. Rolls,et al.  Emotion-related learning in patients with social and emotional changes associated with frontal lobe damage. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[6]  R. Tannock,et al.  Deficient inhibitory control in attention deficit hyperactivity disorder , 1995, Journal of abnormal child psychology.

[7]  T. Robbins,et al.  Dissociation in prefrontal cortex of affective and attentional shifts , 1996, Nature.

[8]  J. Steere,et al.  The alpha-2A noradrenergic receptor agonist guanfacine improves visual object discrimination reversal performance in aged rhesus monkeys. , 1997, Behavioral neuroscience.

[9]  J. Steere,et al.  The α-2A noradrenergic receptor agonist guanfacine improves visual object discrimination reversal performance in aged rhesus monkeys. , 1997 .

[10]  D. Segal,et al.  Effects of Methylphenidate on Extracellular Dopamine, Serotonin, and Norepinephrine: Comparison with Amphetamine , 1997, Journal of neurochemistry.

[11]  J. Evenden Varieties of impulsivity , 1999, Psychopharmacology.

[12]  Joseph Biederman,et al.  Attention-deficit/hyperactivity disorder (adhd) as a noradrenergic disorder , 1999, Biological Psychiatry.

[13]  A. Roberts,et al.  Inhibitory control and affective processing in the prefrontal cortex: neuropsychological studies in the common marmoset. , 2000, Cerebral cortex.

[14]  Gordon D. Logan,et al.  Confirmation of an Inhibitory Control Deficit in Attention-Deficit/Hyperactivity Disorder , 2000, Journal of abnormal child psychology.

[15]  V. Brown,et al.  Medial Frontal Cortex Mediates Perceptual Attentional Set Shifting in the Rat , 2000, The Journal of Neuroscience.

[16]  E. Miller,et al.  An integrative theory of prefrontal cortex function. , 2001, Annual review of neuroscience.

[17]  S. Faraone,et al.  An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder. , 2001, Journal of child and adolescent psychopharmacology.

[18]  R. Kesner,et al.  The role of rat dorsomedial prefrontal cortex in working memory for egocentric responses , 2001, Neuroscience Letters.

[19]  E. Pehek,et al.  Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat , 2002, Brain Research.

[20]  Peter Olausson,et al.  Impairments of Reversal Learning and Response Perseveration after Repeated, Intermittent Cocaine Administrations to Monkeys , 2002, Neuropsychopharmacology.

[21]  Geoffrey Schoenbaum,et al.  Orbitofrontal lesions in rats impair reversal but not acquisition of go, no-go odor discriminations , 2002, Neuroreport.

[22]  K. Perry,et al.  Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder , 2002, Neuropsychopharmacology.

[23]  Hiroyuki Uno,et al.  Orbitofrontal cortex dysfunction in attention-deficit hyperactivity disorder revealed by reversal and extinction tasks , 2002, Neuroreport.

[24]  T. Thiel,et al.  Frontoorbital volume reductions in adult patients with attention deficit hyperactivity disorder , 2002, Neuroscience Letters.

[25]  M. Fillmore,et al.  Impaired inhibitory control of behavior in chronic cocaine users. , 2002, Drug and alcohol dependence.

[26]  R. Wise,et al.  Dopamine Uptake through the Norepinephrine Transporter in Brain Regions with Low Levels of the Dopamine Transporter: Evidence from Knock-Out Mouse Lines , 2002, The Journal of Neuroscience.

[27]  M. Ragozzino,et al.  The effects of dopamine D(1) receptor blockade in the prelimbic-infralimbic areas on behavioral flexibility. , 2002, Learning & memory.

[28]  Sharon Morein-Zamir,et al.  The Effect of Methylphenidate on Three Forms of Response Inhibition in Boys with AD/HD , 2003, Journal of abnormal child psychology.

[29]  T. Robbins,et al.  Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans , 2003, Nature Neuroscience.

[30]  V. Brown,et al.  Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat , 2003, Behavioural Brain Research.

[31]  J. Jentsch,et al.  Genetic vasopressin deficiency facilitates performance of a lateralized reaction time task: Altered attentional and motor processes , 2003, Schizophrenia Research.

[32]  Nora D Volkow,et al.  Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. , 2003, The American journal of psychiatry.

[33]  Adam R Aron,et al.  Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder , 2003, Biological Psychiatry.

[34]  T. Robbins,et al.  Increased response switching, perseveration and perseverative switching following d-amphetamine in the rat , 2004, Psychopharmacology.

[35]  P. Goldman-Rakic,et al.  Selective D2 Receptor Actions on the Functional Circuitry of Working Memory , 2004, Science.

[36]  E. Rolls,et al.  Reward-related Reversal Learning after Surgical Excisions in Orbito-frontal or Dorsolateral Prefrontal Cortex in Humans , 2004, Journal of Cognitive Neuroscience.

[37]  M. Mishkin,et al.  Perseverative interference in monkeys following selective lesions of the inferior prefrontal convexity , 1970, Experimental Brain Research.

[38]  T. Robbins Chemistry of the mind: Neurochemical modulation of prefrontal cortical function , 2005, The Journal of comparative neurology.

[39]  A. Arnsten,et al.  Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions , 2004, Biological Psychiatry.

[40]  David Michelson,et al.  Efficacy of atomoxetine in adult attention-Deficit/Hyperactivity Disorder: a drug-placebo response curve analysis , 2005, Behavioral and Brain Functions.

[41]  A. Arnsten,et al.  Behavioral and Brain Functions , 2005 .

[42]  J. Monterosso,et al.  Deficits in response inhibition associated with chronic methamphetamine abuse. , 2005, Drug and alcohol dependence.

[43]  P. Goldman-Rakic,et al.  Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys , 1994, Psychopharmacology.

[44]  B. Pennington,et al.  Validity of the Executive Function Theory of Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review , 2005, Biological Psychiatry.

[45]  T. Robbins,et al.  Neurochemical Modulation of Response Inhibition and Probabilistic Learning in Humans , 2006, Science.

[46]  M. Fillmore,et al.  Polydrug abusers display impaired discrimination-reversal learning in a model of behavioural control , 2006, Journal of psychopharmacology.

[47]  Lisa M. Saksida,et al.  Genetic and dopaminergic modulation of reversal learning in a touchscreen-based operant procedure for mice , 2006, Behavioural Brain Research.

[48]  L. Vanderschuren,et al.  Behavioral disinhibition requires dopamine receptor activation , 2006, Psychopharmacology.

[49]  C. Swanson,et al.  Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat , 2006, Neuropharmacology.

[50]  A. Arnsten,et al.  Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. , 2006, The Journal of clinical psychiatry.

[51]  L. Vanderschuren,et al.  Critical Involvement of Dopaminergic Neurotransmission in Impulsive Decision Making , 2006, Biological Psychiatry.

[52]  S. Floresco,et al.  Multiple Dopamine Receptor Subtypes in the Medial Prefrontal Cortex of the Rat Regulate Set-Shifting , 2006, Neuropsychopharmacology.

[53]  A. Kelley,et al.  Methylphenidate Preferentially Increases Catecholamine Neurotransmission within the Prefrontal Cortex at Low Doses that Enhance Cognitive Function , 2006, Biological Psychiatry.

[54]  G. Chiara,et al.  Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex , 2006, Journal of neurochemistry.

[55]  D. Morilak,et al.  Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability , 2006, Neuroscience.

[56]  M. Frank,et al.  Anatomy of a decision: striato-orbitofrontal interactions in reinforcement learning, decision making, and reversal. , 2006, Psychological review.

[57]  H. Gu,et al.  Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs , 2006, BMC pharmacology.

[58]  T. Robbins,et al.  Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific. , 2006, Cerebral cortex.

[59]  Trevor W Robbins,et al.  The Orbital Prefrontal Cortex and Drug Addiction in Laboratory Animals and Humans , 2007, Annals of the New York Academy of Sciences.

[60]  Trevor W. Robbins,et al.  Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol , 2007, Psychopharmacology.

[61]  F. Dellu-Hagedorn,et al.  Dimensional Analysis of ADHD Subtypes in Rats , 2007, Biological Psychiatry.

[62]  V. Brown,et al.  Difficulty Overcoming Learned Non‐reward during Reversal Learning in Rats with Ibotenic Acid Lesions of Orbital Prefrontal Cortex , 2007, Annals of the New York Academy of Sciences.

[63]  T. Robbins Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications , 2007, Philosophical Transactions of the Royal Society B: Biological Sciences.

[64]  T. Robbins,et al.  Atomoxetine Improved Response Inhibition in Adults with Attention Deficit/Hyperactivity Disorder , 2007, Biological Psychiatry.

[65]  T. Robbins,et al.  Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat , 2007, Behavioural Brain Research.

[66]  J. Jentsch,et al.  Dopamine D2/D3 Receptors Play a Specific Role in the Reversal of a Learned Visual Discrimination in Monkeys , 2007, Neuropsychopharmacology.

[67]  D. Morilak,et al.  Chronic Treatment with Desipramine Improves Cognitive Performance of Rats in an Attentional Set-Shifting Test , 2007, Neuropsychopharmacology.

[68]  Donna J. Calu,et al.  Withdrawal from cocaine self-administration produces long-lasting deficits in orbitofrontal-dependent reversal learning in rats. , 2007, Learning & memory.

[69]  Michael J. Frank,et al.  Testing Computational Models of Dopamine and Noradrenaline Dysfunction in Attention Deficit/Hyperactivity Disorder , 2007, Neuropsychopharmacology.

[70]  M. Ragozzino The Contribution of the Medial Prefrontal Cortex, Orbitofrontal Cortex, and Dorsomedial Striatum to Behavioral Flexibility , 2007, Annals of the New York Academy of Sciences.

[71]  A. Nairn,et al.  Orbitofrontal Cortex and Cognitive‐Motivational Impairments in Psychostimulant Addiction , 2007, Annals of the New York Academy of Sciences.

[72]  T. Robbins,et al.  Neurobehavioral mechanisms of impulsivity: Fronto-striatal systems and functional neurochemistry , 2008, Pharmacology Biochemistry and Behavior.

[73]  S. Lammel,et al.  Unique Properties of Mesoprefrontal Neurons within a Dual Mesocorticolimbic Dopamine System , 2008, Neuron.

[74]  T. Robbins,et al.  Stop-signal reaction-time task performance: role of prefrontal cortex and subthalamic nucleus. , 2008, Cerebral cortex.

[75]  T. Robbins,et al.  Dissociable Effects of Selective 5-HT2A and 5-HT2C Receptor Antagonists on Serial Spatial Reversal Learning in Rats , 2008, Neuropsychopharmacology.

[76]  M. Day,et al.  Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[77]  Geoffrey Schoenbaum,et al.  The Role of Orbitofrontal Cortex in Drug Addiction: A Review of Preclinical Studies , 2008, Biological Psychiatry.

[78]  T. Robbins,et al.  Similar Effects of the Selective Noradrenaline Reuptake Inhibitor Atomoxetine on Three Distinct Forms of Impulsivity in the Rat , 2008, Neuropsychopharmacology.